Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × Gemcitabine × Clear all

NCT03907475 2026-03-18

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Phase 2 Recruiting

Neoplasm Metastasis

NCT06027268 2026-02-03

ToPCourT

Phase 2 Active not recruiting

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT06790602 2026-01-13

SWITCH

Phase 2 Recruiting

Neoplasm Metastasis

NCT04003610 2025-11-04

Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)

Phase 2 Terminated

7 enrolled 10 charts

Acrocephalosyndactylia, Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT04807816 2025-10-02

TARSARC

Phase 2 Recruiting

Leiomyosarcoma, Neoplasm Metastasis, Sarcoma

NCT02711553 2025-08-03

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

Phase 2 Active not recruiting

309 enrolled 22 charts

Gastrointestinal

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT05821556 2025-07-29

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Phase 2 Recruiting

Neoplasm Metastasis

NCT05673811 2025-04-16

VIRAGE

Phase 2 Completed

Neoplasm Metastasis, Neoplasms

NCT06119217 2024-12-04

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Phase 2 Active not recruiting

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT03678883 2024-11-07

9-ING-41 in Patients with Advanced Cancers

Phase 2 Active not recruiting

BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT03260712 2023-11-03

Pembrolizumab in Biliary Tract Cancer

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasm Metastasis

NCT03567720 2023-06-01

Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

Phase 2 Unknown

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT03487016 2022-09-08

FOOTPATH

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02978716 2022-03-23

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)

Phase 2 Terminated

102 enrolled 51 charts

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT02631590 2021-08-04

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

Phase 2 Completed

24 enrolled 11 charts

Gastrointestinal

Digestive System Neoplasms, Gallbladder Neoplasms, Neoplasm Metastasis, Cholangiocarcinoma

NCT01442662 2020-01-31

LMS03

Phase 2 Completed

Leiomyosarcoma, Neoplasm Metastasis

NCT02106884 2019-11-06

QOLINPAC

Phase 2 Completed

146 enrolled 18 charts

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01309633 2019-07-22

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT00637247 2019-03-20

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Phase 2 Completed

142 enrolled 11 charts

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02560038 2018-11-28

Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer

Phase 2 Terminated

3 enrolled 9 charts

Urinary Bladder Neoplasms, Neoplasm Metastasis

NCT00201760 2017-12-27

Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer

Phase 2 Completed

10 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01964534 2017-01-31

AFUGEM

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00696696 2016-06-30

Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer

Phase 2 Completed

45 enrolled 8 charts

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT00556049 2016-04-21

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Phase 2 Completed

72 enrolled 6 charts

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01599013 2015-12-08

JASINT1

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis, Urogenital Neoplasms, Urologic Neoplasms, Renal Insufficiency

NCT01633645 2015-09-28

Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00998322 2015-04-10

A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma

Phase 2 Completed

Adenocarcinoma, Neoplasm Metastasis

NCT01472770 2014-12-04

GemCaP

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01020006 2014-04-24

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Phase 2 Completed

42 enrolled 8 charts

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01124786 2014-04-17

A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)

Phase 2 Completed

367 enrolled 10 charts

Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT01409005 2014-02-11

Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01045304 2014-01-14

Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00661830 2013-11-21

Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

Phase 2 Completed

103 enrolled 18 charts

Adenocarcinoma, Neoplasm Metastasis

NCT01830322 2013-08-14

Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer

Phase 2 Withdrawn

Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT01834183 2013-06-19

Tivozanib + Gemcitabine in Metastatic RCC

Phase 2 Withdrawn

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT00100789 2012-10-01

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Phase 2 Completed

67 enrolled 10 charts

Lymphoid Interstitial Pneumonia, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasm Metastasis, Recurrence

NCT01655628 2012-08-02

GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT00837239 2012-07-12

Huachansu & Gemcitabine in Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Gastrointestinal Diseases, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00377936 2008-11-14

EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT00758381 2008-10-10

MAPS

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT00436423 2007-11-01

A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT00116389 2007-06-08

Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT00450762 2007-03-22

Gemcitabine + Carboplatin in Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00034593 2006-07-19

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Phase 2 Completed

Urinary Bladder Neoplasms, Neoplasm Metastasis, Urologic Neoplasms